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Abstract. One of 55 patients transplanted for scle-
rosing cholangitis during the cyclosporin-steroid era 
(March 1980-June 1986) developed intrahepatic bil-
iary strictures in the absence of allograft rejection 
within the 1st year posttransplantation. Although 
many causes underlie biliary pathology in the post-
operative period (i. e., arterial injury, ischemia, 
chronic rejection, cholangitis), recurrent disease re-
mains a possibility. 
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Biliary tract complications after orthotopic liver 
transplantation (OLT) are frequent; they are mostly 
due to inappropriate reconstruction of the extrahe-
patic bile duct [1]. Recurrent disease in the allograft 
is common after OLT in malignant biliary tract dis-
ease but is very rare in benign biliary tract disease 
[2-6]. A patient presenting with a possible recurrent 
sclerosing cholangitis some months after liver trans-
plantation is discussed. 
Case report 
On August 21, 1984, a 34 year-old male underwent OLT with a 
graft of identical blood group, type A, for end-stage primary scle-
rosing cholangitis (PSC) (Fig. 1). He had been under medical 
management for severe ulcerative colitis since the age of 21. His 
past medical history revealed an uncomplicated cholecystectomy 
at age 27 and an appendectomy for perforative appendicitis 
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2 years later. During the latter postoperative recovery he 
presented with jaundice, attributed to sclerosing cholangitis. 
Because of persistence of the jaundice, percutaneous biliary 
drainage was attempted in 1982 and 1983. Finally, a choledocho-
jejunostomy was carried out using a transhepatic, trans-
anastomotic U-tube, which was removed 4 months later. Re-
peated evaluations showed a progressive worsening of the liver 
disease, justifying a recommendation for treatment by OLT. The 
cholestasis worsened (total bilirubin, 23 mg%; alkaline phospha-
tases, 2020 IU). Osteoporosis was responsible for compression 
fractures of thoracic vertebrae 8-10 and an aseptic necrosis of the 
left femoral head. Gastrointestinal bleeding due to portal hyper-
tension also occurred. 
The liver grafting was uneventful: the allograft had a single 
arterial supply, the liver was reperfused after the completion of 
all four vascular anastomoses, and cold and warm ischemic times 
were within normal limits. The former Roux-en-Y-jejunal loop 
was reused for the end-to-side choledochojejunostomy. The 
anastomosis was carried out using a 12 French-feeding-tube stent 
and interrupted, absorbable 5-0 vicryl sutures. An intraoperative 
cholangiogram showed a normal intra- and extrahepatic biliary 
tree, an absence of leakage, and a patent anastomosis. The post-
operative course was uneventful and the patient was discharged 
20 days postsurgery with nearly normal liver function tests (LFT) 
[total/conjugated bilirubin (hi!. tl conj), 1.7/0.9 mg% ; alkaline 
phosphatase (alk.phos.) 228 IU; transaminases (SGPT/SGOT), 
150125 lUll; Gamma-glutamyl-transpeptidase (G GTP), 64 IU; 
protime (PT), 11 s]. The rapid postoperative normalization of 
transaminases precluded major ischemic injury to the allograft 
during procurement and reimplantation. 
On January 11, 1985, the patient was readmitted due to ab-
normal LFT (hi!. t., 1.4 mg%; alk. phos., 725 IU; SG PT ISGOT, 
4001268 lUll; G GTP, 204 IU; PT, 12 s). The patient had no 
cholestatic symptoms. The biochemical abnormalities were at-
tributed to an impaired cyclosporin absorption due to large 
amounts of diarrhea associated with a flu. Adjustment of the cy-
closporin dose almost immediately normalized liver function 
(hi!. tl conj, 0.5/0.1 mg%; alk. phos., 341 IU; G GTP, 257 IU; 
SGPT/SGOT, 51128 lUll). A liver biopsy showed early changes 
of bile duct obstruction, such as duct dilatation, portal edema, 
marginal duct proliferation, and ductal ectasia. There were no re-
markable signs of rejection, viral infection, or drug toxicity. 
On February 20, 1985, the patient was rehospitalized due to 
persistent liver function abnormalities in the absence of clinical 
symptoms (hil.tl conj., 1.8/0.2 mg%; alk. phos., 587 IU; 
SGPT ISGOT, 462/321 lUll; G GTP, 365 IU; PT, 11.4 s). A liver 
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Fig. 1. Biochemical evolution and immunosuppressive regimen 
of the case report 
biopsy confirmed changes consistent with biliary obstruction; 
portal fibrosis had worsened. There were almost no signs of graft 
rejection. Direct visualization of the biliary system by transhe-
patic cholangiography revealed poor filling of the peripheral 
ducts and alternation of biliary tract strictures and dilatations. 
The extrahepatic biliary tract and choledochojejunostomy were 
normal. Brushcytology of the intra- and extrahepatic bile ducts 
was negative for tumor cells. Repeated Doppler ultrasonography 
showed normal arterial and venous allograft vascularization. 
Beginning April 1985 the patient underwent a new transhe-
patic cholangiogram due to the development of cholangitis. The 
anastomosis was widely patent. On April 19, 1985, the stent was 
removed. A cholangiogram carried out at that time (Fig.2) con-
Fig. 2. Percutaneous cholangiogram carried out in March 1985, 
confirming the peripheral intrahepatic biliary strictures in the 
presence of a patent biliodigestive anastomosis. The internal 
stent migrated into the jejunal limb 
Fig. 3. Needle liver biopsy specimen, showing portal tract with 
fibrosis, ductular proliferation, and absence of infiltrate as well 
as of vascular changes (H & E, x 96) 
firmed peripheral intrahepatic biliary strictures in the presence of 
a patent choledochojejunostomy. The liver function abnor-
malities persisted on different occasions between May 1985 and 
June 1987 (bil.l., 0.5 mg%; alk. phos., 910 J U; SGPT/ SGOT, 
145 / 82 lUl l; PT, 11.7 s). Histological examinations showed pro-
gression of the biliary obstruction and advancing portal fibrosis 
without evidence of graft rejection (Fig.3). On one occasion, a 
Iymphogranulomatoid nodule was seen near an interlobular bile 
duct (Fig.4). Portal inOammation was otherwise minimal. More 
than 3.5 years posttransplantation, the graft is still functioning 
well, which precludes a further histological examination of the 
organ as well as modification of the low-dose steroid -cyclosporin 
therapy. 
Fig. 4. Allograft liver biopsy ta ken 10 months postoperatively, 
showing portal fibrosis, mild du ct pro life ra tion and dilation . A 
sin gle Iymphogranul o mato id inna mmatory aggregate is seen 
near, but not in volvi ng, a septa l b ile duct (H & E, x 48) 
All posttra nsplant biopsies were obta ined according to a 
pro tocol defining the c rit e ria o f a llograft rejection [6J and pre-
pa red with hematoxy lin-eosi n stai n (H & E), tri chrome orcei n 
and rhoda nine. All sp ec imens we re eva lu a ted for c irrhosis, mar-
gina l ductula r prolifera tion , gra nul omas , porta l or septa l lymph-
oid nodules, the presence a nd loca tion of choles tas is, po rta l 
and/ or central vein subendothe lia l in fi ltration, mo nonuclea r in-
na mmato ry cell damage to bil e ducts, du ctul a r loss, and chronic 
a rteri a l and / or venous les ions as seen in a llogra ft rejection. 
Discussion 
C hanges in the peripheral intrahepatic bile ducts of 
a liver allograft m ay be the express ion of different 
phenomena : (a) inadequate liver procurement, 
(b) inappropriate biliary tract reconstruction or 
(C) arterialization of the allograft, (d) (chronic) allo-
graft rejection, (e) recurrent primary biliary tract 
disease, and (f) primary or recurrent viral hepatitis 
(1, 2, 6, 7, 9]. 
Small intrahepatic ducts may be the primary ta r-
get of damaging immune reactions (6, 8]. Rejection 
can cause rapid destruction of the interlobular bile 
ducts associated with severe centrilobular choles-
tasis, margina l ductular proliferation, and nongran-
ulomatous cell inOammation in the portal tracts . 
This rapidly progressive destruction, consistent with 
a major clinical and chemical cholestatic picture, 
has been described as the " va nishing bile duct syn-
drome" (8]. These alterations occur in different 
form s related to different stages of development or 
to different immunosuppress ive regimens. They 
may even present as nonsuppurative destructive 
cholangitis, resembling the changes seen in primary 
bilia ry cirrhosis (PBq (6, 10]. Only 4 of 604 grafts 
(0.6%) carried out during the period between March 
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1980 and June 1986 had radiological abnormalities 
of the intra hepatic bile ducts s imilar to those de-
scribed in this case report. These abnormalities oc-
curred within the first 12 months after transplanta-
tions carried out for a disease not primarily affect-
ing the biliary tract. All four patients had histologi-
cally proven graft rejection prior to the develop-
ment of intrahepatic bilia ry strictures (2]. 
Recurrent biliary ma lignancy in the allogra ft is 
common after OLT; however, recurrent, primary, 
benign biliary tract disease in the allograft is excep-
tional (6, 7]. Three cases of poss ible, late recurrence 
of PBe a fter OLT have been reported , although the 
changes in the bile duct fell short of those character-
istic of PBe [5]. The liver biopsy changes in these 
pa tients were similar to those seen in chronic, rejec-
tion, viral hepatitis, and graft-versus-host disease. 
Thus, the recurrence of PBe in liver allografts has 
not formally been proven (5]. This was also con-
firmed in our recentl y reviewed series of 76 patients 
grafted during the period from March 1980 to Sep-
tember 1985 for advanced PBe. No instance of re-
current PBe was either clinically or histologica lly 
documented in the 52 surviving recipients with fol-
low-ups of 1-6.5 years (3]. 
During the same period , 55 patients were 
grafted for primary sclerosing cholangitis (PSC) (4]. 
Only 1 of 37 surviving recipients with follow-ups of 
1- 5 years developed chemica l and radiological ab-
normalities of the primary disease 6 months post-
transplantation. The first posttransplant biopsy 
showed minimal or no rejection and early changes 
in biliary obstruction. 
In the subsequent percutaneous biopsies, the 
changes in biliary obstruction and portal fibrosis 
progressed despite the absen ce of rejection. The 
paraductal lymphogranulomatoid nodule seen in 
this case was never observed in our previous trans-
pla nt biopsies (6]. Evidence of rejection or hepatitis 
could not be demonstrated in a ny of the allograft 
biopsies. The normalization of liver function fol -
lowing cyclosporin dose adjustment could be ex-
pla ined by a mitigated rejection episode. However, 
the serial biopsy changes in the absence of allograft 
rejection are indicati ve of biliary tract pathology 
that would be consistent with but by no means diag-
nostic of recurrent sclerosing cholangitis. It is 
possible that the etiology of the intrahepatic bile 
duct strictures in this patient was due to recurrent 
pse, as no other cause or process capable of caus-
ing strictures could be identified. However, since 
there are so many other causes of biliary strictures 
and because the diagnosis depends on a clinico-
pathological correlation, we ca nnot be certain . This 
observation suggests that the recurrence of pse in 
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allografts, if possible, is rare. However, chronic allo-
graft rejection must be ruled out by serial liver bi-
opsies, as peripheral intrahepatic biliary strictures 
can be an unusual consequence (or some modified 
form) of graft rejection. In the present case report, 
the long-term stabilization of the patient's condition 
as well as of his liver function, despite identically 
low immunosuppression, argues against this hy-
pothesis. 
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